Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2005
05/26/2005US20050112760 In vitro culture of tissue structures
05/26/2005US20050112759 Application of electrical stimulation for functional tissue engineering in vitro and in vivo
05/26/2005US20050112744 Glucose dehydrogenase fusion proteins and their use in expression systems
05/26/2005US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/26/2005US20050112723 Mammalian cell lines specifically deficient in O-linked glycosylation
05/26/2005US20050112722 Protein gene expression; high density culture
05/26/2005US20050112707 Method and compositions for inhibiting tumorigenesis
05/26/2005US20050112705 Detecting cancer perticularly of prostate gland
05/26/2005US20050112682 Green fluorescent fusion protein as diagnosis tool; quantitative analysis; colorimetic analysis
05/26/2005US20050112681 Isolated human transporter proteins, nucleic acid molecules encoding human, transporter proteins, and uses thereof
05/26/2005US20050112626 Making and using microclonal uncloned cDNA libraries
05/26/2005US20050112596 APRIL-A novel protein with growth effect
05/26/2005US20050112575 Nucleic acid sequence encoding polypeptides; triggering calcium oscillation in ooctyes ; determination fertility
05/26/2005US20050112574 Isolated nucleic acid; angiogenesis inhibitor
05/26/2005US20050112568 Dgks as modifiers of the p53 pathwha and methods of use
05/26/2005US20050112565 Proteases
05/26/2005US20050112556 Drug screening; endogenous human retrovirus; protein or peptide expressed by said retrovirus
05/26/2005US20050112546 Neural colony forming assay
05/26/2005US20050112541 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
05/26/2005US20050112141 Compositions and methods for treatment of neoplastic disease
05/26/2005US20050112127 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
05/26/2005US20050112126 Anti-VEGF antibodies
05/26/2005US20050112119 Antibodies which bind human CXCR3
05/26/2005US20050112117 Molecules and methods for inhibiting shedding of KIM-1
05/26/2005US20050112110 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators
05/26/2005US20050112109 Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain
05/26/2005US20050112106 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
05/26/2005US20050112105 Compositions and treatments for myelosuppression by ex vivo activated immune cells
05/26/2005US20050112104 Forming cardiomyocytes in vivo using mesenchymal stem cells; cell differentiation
05/26/2005US20050112103 Genetic engineered vectors encoding human low density lipoproteins ; control sequencing, gene expressionin heptacytes; anticholesterol agents; antilipemic agents
05/26/2005US20050112096 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
05/26/2005CA2552686A1 Isolation of nucleic acid from mouth epithelial cells
05/26/2005CA2547474A1 Genes differentially expressed by acutely isolated resident progenitor cells of the human white matter
05/26/2005CA2546323A1 Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use
05/26/2005CA2545938A1 High-titer retroviral packaging cells
05/26/2005CA2545454A1 Adenocarcinoma specific antibody sam-6, and uses thereof
05/26/2005CA2545409A1 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
05/26/2005CA2545182A1 Improved methods and compositions for rna interference
05/26/2005CA2545164A1 Recombinant vectors expressing mucin and carcinoembryoinic antigen
05/26/2005CA2544726A1 Artificial tissue systems and uses thereof
05/26/2005CA2544688A1 Cellular membrane protein assay
05/26/2005CA2544564A1 Methods, compositions, and automated systems for separating rare cells from fluid samples
05/26/2005CA2544347A1 Motoneuronotrophic factor gene sequences
05/26/2005CA2544308A1 Cytokine antagonist molecules
05/26/2005CA2544252A1 Stem cell culture medium and method of using said medium and the cells
05/26/2005CA2543920A1 Il-18 binding proteins
05/26/2005CA2543631A1 Monkey immunoglobulin sequences
05/26/2005CA2542574A1 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
05/26/2005CA2542564A1 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast
05/26/2005CA2536645A1 Long-wavelength fps
05/25/2005EP1533617A1 Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
05/25/2005EP1533381A1 Adenovirus vector
05/25/2005EP1533380A2 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
05/25/2005EP1533370A1 Novel atypical pneumonia-causing virus
05/25/2005EP1533367A1 Use of collagenase in the preparation of neural stem cell cultures
05/25/2005EP1533366A1 Chitosan/acidic biopolymer hybrid fiber and culture base for animal cells
05/25/2005EP1532453A1 Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
05/25/2005EP1532452A2 Heterologous stimulus-gated ion channels and methods of using same
05/25/2005EP1532446A2 G-protein coupled receptor ligands and methods
05/25/2005EP1532259A1 Non-human herpesviruses as vectors
05/25/2005EP1532254A2 Helper virus-free herpesvirus amplicon particles and uses thereof
05/25/2005EP1532253A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
05/25/2005EP1532251A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use
05/25/2005EP1532248A1 Modified small interfering rna molecules and methods of use
05/25/2005EP1532247A2 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof
05/25/2005EP1532242A2 Methods for preparing purified prostaglandin e synthase
05/25/2005EP1532239A2 Methods and compositions for targeting secretory lysosomes
05/25/2005EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/25/2005EP1532174A2 Anti-igf-i receptor antibody
05/25/2005EP1532169A1 Variants of the major allergen phl p 1 from timothy grass
05/25/2005EP1532165A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
05/25/2005EP1532163A2 Androgen receptor coregulators
05/25/2005EP1531870A1 Selected cell delivery for heart failure
05/25/2005EP1531865A2 Methods and compositions for the repair and/or regeneration of damaged myocardium
05/25/2005EP1531864A2 Humanized antibodies against the venezuelan equine encephalitis virus
05/25/2005EP1531863A2 Antibody-avidin fusion proteins as cytotoxic drugs
05/25/2005EP1531859A1 Compositions and methods for transepithelial molecular transport
05/25/2005EP1531848A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
05/25/2005EP1531823A2 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
05/25/2005EP1531677A2 Three dimensional vaginal tissue model containing immune cells
05/25/2005EP1531676A2 Compositions and methods for liver growth and liver protection
05/25/2005EP1531666A1 Inducible eukaryotic expression system
05/25/2005EP1497410A4 Cellular transplantation for heart regeneration
05/25/2005EP1461431A4 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
05/25/2005EP1455854B1 Skin/hair equivalent with reconstructed papillae
05/25/2005EP1438390A4 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
05/25/2005EP1397513B1 Novel technology for genetic mapping
05/25/2005EP1372670B1 Caloporoside derivatives, methods for the production thereof and their use
05/25/2005EP1165615B1 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
05/25/2005EP1163335B1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
05/25/2005EP1002115B1 Universal chloroplast integration and expression vectors, transformed plants and products thereof
05/25/2005EP0981637B1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
05/25/2005EP0871702B1 Cytokine designated lerk-7
05/25/2005EP0813419B1 Modulators of regulatory proteins
05/25/2005EP0688227B1 Production of human papillomavirus capsid protein and virus-like particles
05/25/2005EP0479866B2 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus
05/25/2005DE202004019129U1 Genetically-modified rodent for use in established experimental systems, exhibits homozygote knock-out of interferon receptor alpha-chain
05/25/2005DE10349484A1 Verfahren und Bioreaktor zum Kultivieren und Stimulieren von dreidimensionalen, vitalen und mechanisch widerstandsfähigen Zelltransplantaten Method and bioreactor for the culture and stimulating three-dimensional, vital and mechanically resistant cell transplants
05/25/2005CN1620655A System and method for controlling user interface attribute by data
05/25/2005CN1620510A Cytokine protein family
1 ... 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 ... 1827